Telephone-Based Support Programs for People With Epilepsy

Epilepsy Clinical Trial

Official title: NYU Managing Epilepsy Well (MEW) Study: A Randomized Controlled Trial of Telephone-Based Support for People With Epilepsy

Status Recruiting

Clinical Trial Summary

This is a two-arm randomized controlled trial to compare telephone-based depression self-management (UPLIFT) to telephone-based support groups (BOOST). A sample of 120 English- and Spanish-speaking people with epilepsy (PWE) with elevated depressive symptoms will be enrolled. Both interventions are 8-week programs delivered in one-hour weekly sessions to groups of about 6 participants. Changes in depressive symptoms, quality of life and seizures will be assessed over 12 months. The trial will also examine mediators and moderators of treatment effects.

Clinical Trial Description

The objectives of the trial are:

1. To test effects of UPLIFT versus BOOST on changes in depressive symptoms (primary outcome) in PWE over 12 months.

2. To test effects of UPLIFT versus BOOST on changes in quality of life and seizures (secondary outcomes) in PWE over 12 months.

3. To test whether intervention effects are mediated by increases in mindfulness and decreases in rumination.

4. To test whether intervention effects are moderated by participant characteristics and facilitator characteristics. ;

Related Conditions & MeSH terms

• Epilepsy

• NCT number: NCT05082181
• Study type: Interventional
• Source: NYU Langone Health
• Contact: Tanya Spruill, PhD
• Phone: 646-501-3429
• Email: Tanya.Spruill@nyulangone.org
• Status: Recruiting
• Phase: N/A
• Start date: November 9, 2021
• Completion date: August 31, 2025